Towards Selective Antagonists of T-Type Calcium Channels: Design, Characterization and Potential Applications of NNC 55-0396-Reference-Cited by-同舟云学术

Towards Selective Antagonists of T-Type Calcium Channels: Design, Characterization and Potential Applications of NNC 55-0396

Published:2006-06-07 Issue:2 Volume:23 Page:173-196
ISSN:0897-5957
Container-title:Cardiovascular Drug Reviews
language:en
Short-container-title:

Author:

Li Ming,Hansen J. Bondo,Huang Luping,Keyser Brian M.,Taylor James T.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1527-3466.2005.tb00164.x/fullpdf

Reference134 articles.

1. Low-voltage-activated calcium current in rat aorta smooth muscle cells in primary culture;Akaike;J Physiol,1989

2. Two distinct populations of calcium channels in a clonal line of pituitary cells;Armstrong;Science,1985

3. Pharmacological properties of T-type Ca2+ current of mouse spermatogenic cells;Arnoult;Mol Pharmacol,1998

4. Establishment of 2-mercaptothanol-dependent differentiated insulin-secreting cell lines;Asfari;Endocrinology,1992

5. L-type calcium channels: Asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyri dines;Bangalore;Mol Pharmacol,1994

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Drug Development Overview: Targeting Voltage-Gated Calcium Channels for the Treatment of Pain;International Journal of Molecular Sciences;2023-05-25

2. A repositioning screen using an FGFR2 splicing reporter reveals compounds that regulate epithelial-mesenchymal transitions and inhibit growth of prostate cancer xenografts;Molecular Therapy - Methods & Clinical Development;2022-06

3. Tetralol derivative NNC-55-0396 induces glioblastoma cell death by activating IRE1α, JNK1 and calcium signaling;Biomedicine & Pharmacotherapy;2022-05

4. Cav3 T-Type Voltage-Gated Ca2+ Channels and the Amyloidogenic Environment: Pathophysiology and Implications on Pharmacotherapy and Pharmacovigilance;International Journal of Molecular Sciences;2022-03-22

5. Сardioprotective agents with biaromatic structure. Part 1. Calcium channel blockers;Pharmacokinetics and Pharmacodynamics;2022-02-21